NeuroPace (NPCE) FCF Margin (QoQ) (2020 - 2026)
NeuroPace (NPCE) FCF Margin (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.77 Bn | 194.17 Bn | 7.27 Bn |
| 2 | Stryker | 126.93 Bn | 123.46 Bn | 4.50 Bn |
| 3 | Medtronic | 118.80 Bn | 109.58 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.18 Bn | 72.64 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.06 Bn | 47.81 Bn | 1.35 Bn |
| 6 | Dexcom | 34.34 Bn | 32.40 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.79 Bn | 31.69 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.03 Bn | 22.55 Bn | 684.20 Mn |
| 10 | NeuroPace | 474.05 Mn | 422.35 Mn | 18.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 962.00 |
| Mar 31, 2026 | -2,878.00 |
| Dec 31, 2025 | 869.00 |
| Sep 30, 2025 | 233.00 |
| Jun 30, 2025 | 2,396.00 |
| Mar 31, 2025 | -1,272.00 |
| Dec 31, 2024 | -1,185.00 |
| Sep 30, 2024 | 1,209.00 |
| Jun 30, 2024 | 2,070.00 |
| Mar 31, 2024 | -2,319.00 |
| Dec 31, 2023 | -444.00 |
| Sep 30, 2023 | 1,261.00 |
| Jun 30, 2023 | 4,126.00 |
| Mar 31, 2023 | -556.00 |
| Dec 31, 2022 | -1.00 |
| Sep 30, 2022 | 4,685.00 |
| Jun 30, 2022 | -870.00 |
| Mar 31, 2022 | -2,330.00 |
| Dec 31, 2021 | -3,398.00 |
| Sep 30, 2021 | 509.00 |